NCT05285358

Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases

SUSPENDEDPHASE1INTERVENTIONAL

Trial Details

Start: 2022-09-19Est. Completion: 2028-10-11

Enrollment target: 12 participants

Locations

City of Hope Medical Center, Duarte, California, United States

Other microbiome trials you might be interested in

Endoscopic Drainage of Presumed Resectable pCCA Using an Intrahepatic Plastic Stent With Retrieval StringCompleted

Perihilar Cholangiocarcinoma

Prospective pilot study to assess the feasibility and efficacy of intrahepatic plastic biliary stents with a retrieval s…

Amsterdam, NetherlandsCompleted May 21, 2026

View Trial →

Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)Phase 2Recruiting

Advanced Biliary Tract CarcinomaAdvanced Gallbladder CarcinomaAdvanced Intrahepatic CholangiocarcinomaRecurrent Biliary Tract CarcinomaRecurrent Gallbladder CarcinomaRecurrent Intrahepatic CholangiocarcinomaStage III Distal Bile Duct Cancer AJCC v8

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.